We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$42.7M
AUM Growth
-$578K
Cap. Flow
-$1.39M
Cap. Flow %
-3.25%
Top 10 Hldgs %
98.2%
Holding
16
New
4
Increased
3
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
NPKI
NPK International
NPKI
+$2.33M
2
CDNA icon
CareDx
CDNA
+$1.08M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$490K
4
DMAC icon
DiaMedica Therapeutics
DMAC
+$487K
5
AEM icon
Agnico Eagle Mines
AEM
+$478K

Top Sells

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$2.8M
2
HON icon
Honeywell
HON
+$1.69M
3
UAL icon
United Airlines
UAL
+$1.21M
4
BELFB
Bel Fuse Inc Class B
BELFB
+$479K
5
AKYA
Akoya BioSciences
AKYA
+$285K

Sector Composition

Rank Sector Weight
1 Materials 38.57%
2 Energy 31.05%
3 Healthcare 12.63%
4 Technology 11.97%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEM icon
1
Agnico Eagle Mines
AEM
$93.8B
$14.1M 33.03%
130,000
+5,000
+4% +$478K
NVGS icon
2
Navigator Holdings
NVGS
$1.26B
$7.99M 18.72%
600,000
– –
EPSN icon
3
Epsilon Energy
EPSN
$180M
$5.26M 12.33%
745,000
– –
BELFB
4
Bel Fuse Inc Class B
BELFB
$4.25B
$4.64M 10.88%
62,000
-6,000
-9% -$479K
NPKI
5
NPK International
NPKI
$1.19B
$2.47M 5.79%
425,000
+350,000
+467% +$2.33M
FNV icon
6
Franco-Nevada
FNV
$45.5B
$2.36M 5.54%
15,000
-20,000
-57% -$2.8M
DMAC icon
7
DiaMedica Therapeutics
DMAC
$369M
$2.27M 5.33%
600,000
+85,216
+17% +$487K
IRIX icon
8
IRIDEX
IRIX
$15.1M
$990K 2.32%
1,000,000
– –
AKYA
9
DELISTED
Akoya BioSciences
AKYA
$933K 2.19%
671,000
-130,000
-16% -$285K
CDNA icon
10
CareDx
CDNA
$2.45B
$888K 2.08%
+50,000
New +$1.08M
KSPI icon
11
Kaspi.kz JSC
KSPI
$18.9B
$464K 1.09%
+5,000
New +$490K
QTRX icon
12
Quanterix
QTRX
$139M
$163K 0.38%
+25,000
New +$209K
PRGO icon
13
Perrigo
PRGO
$1.76B
$140K 0.33%
+5,000
New +$130K
ASPI icon
14
ASP Isotopes
ASPI
$541M
– –
-25,000
Closed -$113K
HON icon
15
Honeywell
HON
$74.6B
– –
-7,958
Closed -$1.69M
UAL icon
16
United Airlines
UAL
$40.6B
– –
-12,500
Closed -$1.21M

Similar funds

TWM
Tripletail Wealth Management Orlando, Florida $73.4M AUM 26.64% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WH
Wallace Hart Lexington, Kentucky $72.6M AUM 34.63% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $72M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $75.2M AUM 15.62% 1-Year Est. Return
OC
Owlhouse Capital New York $75.3M AUM
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's Q1 2025 Portfolio in Review

As of Q1 2025, Paragon Associates & Paragon Associates II Joint Venture held 16 positions worth $42.7M, down 1.3% from $43.2M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture withdrew a net $1.39M in Q1 2025, closing 3 positions and reducing 3 holdings. Its most notable exit was Honeywell, an estimated $1.69M position sold in full.

By sector, the portfolio is most concentrated in Materials at 39% of assets, up from 32% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Paragon Associates & Paragon Associates II Joint Venture opened a new position in CareDx worth $888K.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q1 2025 buy was CareDx: 50,000 shares worth $888K.
  • Paragon Associates & Paragon Associates II Joint Venture added most to NPK International in Q1 2025, an estimated $2.33M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q1 2025 reduction was Franco-Nevada, cutting an estimated $2.8M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited Honeywell in Q1 2025, selling an estimated $1.69M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 98% of its $42.7M portfolio in Q1 2025.
  • Paragon Associates & Paragon Associates II Joint Venture opened 4 new positions and closed 3 in Q1 2025.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 1.3% quarter-over-quarter to $42.7M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2025, filed 13 May 2025.